封面
市场调查报告书
商品编码
1632600

全球合成橡胶输液帮浦市场:市场规模、份额和趋势分析(按产品、应用、最终用途、地区和细分市场,2025-2030 年)

Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

合成橡胶输液帮浦的市场趋势:

2024 年全球合成橡胶输液帮浦市场价值预估为 6.798 亿美元,预估 2025 年至 2030 年期间复合年增长率为 7.2%。

癌症、糖尿病和心血管疾病等慢性病发生率的上升是市场成长的主要动力。根据世界卫生组织(WHO)统计,慢性病是全球首要死亡原因,占全球整体的71%。这导致对合成橡胶帮浦等持续药物传输系统的需求增加,以确保有效治疗和管理这些疾病。

对居家医疗解决方案的需求不断增长是推动合成橡胶输液帮浦产业发展的关键因素。患者更喜欢可以在家中用药的治疗治疗方法,合成橡胶帮浦的便携性和易用性满足了这项需求。人口老化进一步加强了这一趋势,对慢性病的长期治疗的需求更大。根据2024年10月发表的一项研究,骨髓炎在美国每年影响约5万人,儿童、老年人和男性的发生率较高。椎骨和长骨是最常受影响的部位。此外,本研究和其他已发表的有关该疾病的资料也证明,男性骨髓炎的发生率高于女性。

製造商正专注于增强合成橡胶输液帮浦技术以推动市场成长。这些进步包括更高的精度、更长的注射时间、更完善的泵浦的开发以及更易于设计。这些创新旨在满足患者和医疗保健提供者的多样化需求,并使合成橡胶输液帮浦更加高效、可靠和安全。 2024 年 9 月发表在《生物科学与医学杂誌》上的一项研究提出了一种可透过导管输送药物的合成橡胶泵的理论模型。在这项研究中,准确地再现了临床流速,并确定了与球体半径相关的毒性凸起。研究人员得出结论,透过优化帮浦的特性,可以控制输液时间,同时最大限度地减少毒性作用。

减少阿片类药物成瘾和改善患者获得替代疼痛管理解决方案的机会的日益增长的动力是医疗政策改变的主要驱动力。 2024年11月,Avanos Medical, Inc.报告称,医疗保险和医疗补助服务中心已完成2025年医疗保险医院门诊病人预付费系统和门诊手术中心付费系统规则,该规则将于2025年1月1日生效。此次更新引入了《NOPAIN法案》,该法案要求医疗保险为涵盖的非阿片类药物和设备提供明确的费用,以改善患者在医院门诊和外科中心获得疼痛管理解决方案的机会。

目录

第一章 分析方法及范围

第 2 章执行摘要

第三章合成橡胶输液帮浦市场:因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 合成橡胶输液帮浦市场:分析工具
    • 产业分析:波特五力分析
    • PESTEL 分析

第 4 章合成橡胶输液帮浦市场:按产品进行的估计与趋势分析

  • 全球合成橡胶输液帮浦市场:产品特定仪表板
  • 全球合成橡胶输液帮浦市场:依产品进行的变化分析
  • 全球合成橡胶输液帮浦市场依产品划分(以收益为准)
  • 定速合成橡胶输液泵
  • 变速弹性合成橡胶输液泵

第 5 章合成橡胶输液帮浦市场:按应用进行评估与趋势分析

  • 全球合成橡胶输液帮浦市场:按应用分類的仪表板
  • 全球合成橡胶输液帮浦市场:按应用进行的变化分析
  • 全球合成橡胶输液帮浦市场按应用划分(以收益为准)
  • 疼痛管理
  • 化疗
  • 抗生素/抗病毒治疗
  • 其他的

第 6 章合成橡胶输液帮浦市场:依最终用途的估计与趋势分析

  • 全球合成橡胶输液帮浦市场:依最终用途分類的仪表板
  • 全球合成橡胶输液帮浦市场:依最终用途进行的变化分析
  • 全球合成橡胶输液帮浦市场按最终用途划分(以收益为准)
  • 医院
  • 门诊手术中心
  • 其他的

第 7 章合成橡胶输液帮浦市场:区域估计与趋势分析(按国家、产品、应用和最终用途)

  • 区域控制面板
  • 市场规模预测及趋势分析(2018年及2030年)
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 最新趋势和影响分析:按主要製造商
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 主要企业市场占有率分析(2024年)
  • 公司简介
    • Baxter
    • Fresenius Kabi AG
    • B. Braun SE
    • Ambu A/S
    • Leventon, SAU
    • NIPRO
    • Terumo Corporation
    • AVNS
    • Vygon Group
    • Smiths Group plc
Product Code: GVR-4-68040-340-4

Elastomeric Infusion Pumps Market Trends:

The global elastomeric infusion pumps market size was estimated at USD 679.8 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030. The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a significant driver for market growth. According to statistics from the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for 71% of all deaths globally. This led to a higher demand for continuous drug delivery systems such as elastomeric pumps to ensure effective treatment and management of these conditions.

The growing demand for home healthcare solutions is a crucial factor driving the elastomeric infusion pumps industry. Patients prefer therapies that enable them to administer medications at home, and the portability and user-friendliness of elastomeric pumps cater to this need. This trend is amplified by the aging population's increasing requirement for long-term treatment of chronic conditions. According to a study published in October 2024, Osteomyelitis affects around 50,000 people annually in the U.S., with higher incidence in children, older adults, and males. Vertebrae and long bones are the most commonly involved sites. It also shows that males are more susceptible to Osteomyelitis than females, as evidenced by the current research and other published data on the disease.

Manufacturers are focusing on enhancing elastomeric infusion pump technologies to drive market growth. These advancements involve greater accuracy, longer infusion durations, developing pumps with improved features, and accessible designs. These innovations aim to cater to the diverse needs of patients and healthcare providers, enhancing the efficiency of elastomeric infusion pumps and making them dependable and secure. In September 2024, research published in the Journal of Biosciences and Medicines presented a theoretical model for elastomeric pumps, which deliver medications through a catheter. The study accurately reproduced clinical flow rates and identified a toxicity bump related to the sphere's radius. The researchers concluded that by optimizing pump properties, infusion times can be controlled while minimizing toxicity effects.

The increasing push to reduce opioid dependence and improve patient access to alternative pain management solutions has been a major driver in healthcare policy changes. In November 2024, Avanos Medical, Inc. reported that the Centers for Medicare and Medicaid Services has finalized its Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System regulations for 2025, set to take effect on January 1, 2025. This update introduces the NOPAIN Act, which requires Medicare to provide distinct payments for eligible non-opioid medications and devices to improve patient access to pain management solutions in hospital outpatient and surgical center environments.

Global Elastomeric Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global elastomeric infusion pumps market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Continuous Rate Elastomeric Infusion Pumps
  • Variable Rate Elastomeric Infusion Pumps
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Pain Management
  • Chemotherapy
  • Antibiotic/Antiviral Therapy
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Elastomeric Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Rising number of orthopedic surgeries
      • 3.2.1.3. Technological advancements in elastomeric infusion pumps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of elastomeric infusion pumps
      • 3.2.2.2. Regulatory standards
  • 3.3. Elastomeric Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Elastomeric Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. Global Elastomeric Infusion Pumps Market: Product Dashboard
  • 4.2. Global Elastomeric Infusion Pumps Market: Product Movement Analysis
  • 4.3. Global Elastomeric Infusion Pumps Market by Product, Revenue
  • 4.4. Continuous Rate Elastomeric Infusion Pumps
    • 4.4.1. Continuous Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Variable Rate Elastomeric Infusion Pumps
    • 4.5.1. Variable Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Elastomeric Infusion Pumps Market: Application Estimates & Trend Analysis

  • 5.1. Global Elastomeric Infusion Pumps Market: Application Dashboard
  • 5.2. Global Elastomeric Infusion Pumps Market: Application Movement Analysis
  • 5.3. Global Elastomeric Infusion Pumps Market by Application, Revenue
  • 5.4. Pain Management
    • 5.4.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Chemotherapy
    • 5.5.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Antibiotic/Antiviral Therapy
    • 5.6.1. Antibiotic/antiviral therapy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Elastomeric Infusion Pumps Market: End Use Estimates & Trend Analysis

  • 6.1. Global Elastomeric Infusion Pumps Market: End Use Dashboard
  • 6.2. Global Elastomeric Infusion Pumps Market: End Use Movement Analysis
  • 6.3. Global Elastomeric Infusion Pumps Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Elastomeric Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Baxter
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Fresenius Kabi AG
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. B. Braun SE
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Ambu A/S
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Leventon, S.A.U.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. NIPRO
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Terumo Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. AVNS
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Vygon Group
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Smiths Group plc
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global elastomeric infusion pumps market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 30 France elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 31 France elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 52 China elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 53 China elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 58 India elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 59 India elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America elastomeric infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait elastomeric infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait elastomeric infusion pumps market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait elastomeric infusion pumps market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Elastomeric infusion pumps market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Elastomeric Infusion Pumps Market: Product Outlook Key Takeaways
  • Fig. 15 Global Elastomeric Infusion Pumps Market: Product Movement Analysis
  • Fig. 16 Global Continuous Rate Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Variable Rate Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Elastomeric Infusion Pumps Market: Application Outlook Key Takeaways
  • Fig. 19 Global Elastomeric Infusion Pumps Market: Application Movement Analysis
  • Fig. 20 Global Pain Management Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Chemotherapy Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Antibiotic/Antiviral Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Elastomeric Infusion Pumps Market: End Use Outlook Key Takeaways
  • Fig. 25 Global Elastomeric Infusion Pumps Market: End Use Movement Analysis
  • Fig. 26 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Global Elastomeric Infusion Pumps Market: Region Movement Analysis
  • Fig. 32 North America Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 33 US Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia pacific Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Elastomeric Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 60 Strategy framework